NASDAQ:BBOT | Profit Breakdown | BridgeBio Oncology Therapeutics, Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2023-12-31 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30-$60.19M-$56.45M
2026-03-31-$46.18M-$42.11M
2025-12-31-$43.41M-$38.8M
2025-09-30-$49.18M-$44.76M
2025-06-30-$30.09M-$28.44M
2025-03-31-$23.14M-$22.06M
2024-12-31-$21.88M-$19.69M
2024-09-30-$19.66M-$17.32M
2024-06-30-$152,343.00-$21.82M
2024-03-31-$66,701.00-$15.44M

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31-$145.82M-$134.04M
2024-12-31-$80.86M-$74.28M
2023-12-31-$41,692.00-$41,692.00